Article thumbnail

Src activates Abl to augment Robo1 expression in order to promote tumor cell migration

By P. Raaj Khusial, Bhaskar Vadla, Harini Krishnan, Trudy F. Ramlall, Yongquan Shen, Hitoshi Ichikawa, Jian-Guo Geng and Gary S. Goldberg


Cell migration is an essential step in cancer invasion and metastasis. A number of orchestrated cellular events involving tyrosine kinases and signaling receptors enable cancer cells to dislodge from primary tumors and colonize elsewhere in the body. For example, activation of the Src and Abl kinases can mediate events that promote tumor cell migration. Also, activation of the Robo1 receptor can induce tumor cell migration. However, while the importance of Src, Abl, and Robo1 in cell migration have been demonstrated, molecular mechanisms by which they collectively influence cell migration have not been clearly elucidated. In addition, little is known about mechanisms that control Robo1 expression. We report here that Src activates Abl to stabilize Robo1 in order to promote cell migration. Inhibition of Abl kinase activity by siRNA or kinase blockers decreased Robo1 protein levels and suppressed the migration of transformed cells. We also provide evidence that Robo1 utilizes Cdc42 and Rac1 GTPases to induce cell migration. In addition, inhibition of Robo1 signaling can suppress transformed cell migration in the face of robust Src and Abl kinase activity. Therefore, inhibitors of Src, Abl, Robo1 and small GTPases may target a coordinated pathway required for tumor cell migration

Topics: Research Papers
Publisher: Impact Journals LLC
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). A crucial role in cell spreading for the interaction of Abl 208 Oncotarget 2010; 1: 198-209 PxxP motifs with Crk and Nck adaptors. J.Cell Sci.
  2. (2004). A renaissance for SRC.
  3. (2007). A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo. Cancer Res.
  4. (2005). Action of the Src family kinase inhibitor, dasatinib (BMS354825), on human prostate cancer cells. Cancer Res.
  5. (2008). Activated c-Abl tyrosine kinase in malignant solid tumors. Oncogene
  6. (2006). Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells. Cancer Res.
  7. (2002). Activation of the repulsive receptor Roundabout inhibits N-cadherinmediated cell adhesion. Nat.Cell Biol.
  8. (2006). Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance. Proc.Natl.Acad.Sci.U.S.A
  9. (2006). Allosteric inhibitors of Bcr-abl-dependent cell proliferation. Nat.Chem Biol.
  10. (2005). Breast cancer metastasis: markers and models. Nat.Rev.Cancer
  11. (1999). c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev.
  12. (2007). Cables links Robo-bound Abl kinase to N-cadherinbound beta-catenin to mediate Slit-induced modulation of adhesion and transcription. Nat.Cell Biol.
  13. (2000). Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res.
  14. (2008). Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Cancer Sci.
  15. (2005). Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin.Cancer Res.
  16. (2005). Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res.
  17. (1996). Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ.
  18. (2005). Genes that mediate breast cancer metastasis to lung. Nature
  19. (2006). Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin.Cancer Res.
  20. (2003). Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell
  21. (1998). Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J.Cell Biol.
  22. (2004). Newest findings on the oldest oncogene; how activated src does it. J.Cell Sci.
  23. (2004). Normal cells control the growth of neighboring transformed cells independent of gap junctional communication and SRC activity. Cancer Res.
  24. (2007). Phosphorylation of connexin43 induced by Src: Regulation of gap junctional communication between transformed cells. Exp.Cell Res.
  25. (2006). Potential role of the Slit/Robo signal pathway in angiogenesis. Vasc.Med.
  26. (2009). Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration. Oncogene
  27. (2000). Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor. Cell
  28. (2004). Rho GTPases have diverse effects on the organization of the actin filament system.
  29. (2002). Rho GTPases in cell biology.
  30. (2005). Rho GTPases: biochemistry and biology. Annu.Rev.Cell Dev.Biol.
  31. (2000). Role of Src expression and activation in human cancer. Oncogene
  32. (2001). Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell
  33. (2008). Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis.
  34. (2008). Src family kinases: regulation of their activities, levels and identification of new pathways.
  35. (2003). Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells.
  36. (2006). SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res.
  37. (2007). Src utilizes Cas to block gap junctional communication mediated by connexin43. J.Biol.Chem.
  38. (2008). Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemicalinduced squamous cell carcinogenesis. Cancer Sci.
  39. (1998). The conserved immunoglobulin superfamily member SAX-3/Robo directs multiple aspects of axon guidance in C. elegans. Cell
  40. (1994). The COOH terminus of the c-Abl tyrosine kinase contains distinct Fand G-actin binding domains with bundling activity. J.Cell Biol.
  41. (2004). The effects of connexin phosphorylation on gap junctional communication. Int.J.Biochem.Cell Biol.
  42. (2007). The neuronal guidance cue Slit2 induces targeted migration and may play a role 209 Oncotarget 2010; 1: 198-209 in brain metastasis of breast cancer cells. Breast Cancer Res.Treat.
  43. (1991). Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc.Natl.Acad.Sci.U.S.A
  44. (2009). WASP and WAVE proteins: vital intrinsic regulators of cell motility and their role in cancer (review).